Search results
Results from the WOW.Com Content Network
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
The Modified Checklist for Autism in Toddlers (M-CHAT) is a psychological questionnaire that evaluates risk for autism spectrum disorder in children ages 16–30 months. The 20-question test is filled out by the parent, and a follow-up portion is available for children who are classified as medium- to high-risk for autism spectrum disorder.
The Checklist for Autism in Toddlers (CHAT) is a psychological questionnaire designed to evaluate risk for autism spectrum disorder in children ages 18–24 months. The 14-question test is filled out by the parent and a pediatrician or physician and takes approximately 5 minutes to complete. [ 1 ]
assess autism in children, adolescents, and adults The Autism Diagnostic Observation Schedule ( ADOS ) is a standardized diagnostic test for assessing autism spectrum disorder . The protocol consists of a series of structured and semi-structured tasks that involve social interaction between the examiner and the person under assessment.
The drug formulation (immediate release, excipients used, manufacturing methods, modified release – delayed release, extended release, sustained release, etc.) Whether the formulation is administered in a fed or fasted state; Gastric emptying rate; Circadian differences; Interactions with other drugs/foods:
Autism spectrum disorder is a new diagnosis that incorporates the former diagnoses of classic autism, Asperger disorder, childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified (PDD-NOS)—see Diagnosis of Asperger syndrome § DSM-5 changes.
Useful for diagnosing autism, planning treatment, and distinguishing autism from other developmental disorders. The interview covers the referred individual's full developmental history, is usually conducted in an office, home or other quiet setting by a psychologist, and generally takes one to two hours.